Centene Corp has a consensus price target of $89.84 based on the ratings of 32 analysts. The high is $110 issued by Oppenheimer on June 21, 2024. The low is $70 issued by Credit Suisse on September 14, 2021. The 3 most-recent analyst ratings were released by Wells Fargo, Truist Securities, and Jefferies on July 22, 2024, July 15, 2024, and July 11, 2024, respectively. With an average price target of $84.33 between Wells Fargo, Truist Securities, and Jefferies, there's an implied 25.87% upside for Centene Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/22/2024 | Buy Now | 20.9% | Wells Fargo | Stephen Baxter | $93 → $81 | Maintains | Overweight | Get Alert |
07/15/2024 | Buy Now | 32.84% | Truist Securities | Ryan MacDonald | $92 → $89 | Maintains | Buy | Get Alert |
07/11/2024 | Buy Now | 23.88% | Jefferies | David Windley | $90 → $83 | Maintains | Buy | Get Alert |
07/10/2024 | Buy Now | 19.4% | JP Morgan | Calvin Sternick | $85 → $80 | Maintains | Neutral | Get Alert |
06/21/2024 | Buy Now | 64.18% | Oppenheimer | Michael Wiederhorn | $110 → $110 | Reiterates | Outperform → Outperform | Get Alert |
06/12/2024 | Buy Now | 34.33% | Cantor Fitzgerald | Sarah James | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
05/30/2024 | Buy Now | 23.88% | Stephens & Co. | Scott Fidel | $83 → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
05/30/2024 | Buy Now | 23.88% | Baird | Michael Ha | → $83 | Initiates | → Neutral | Get Alert |
05/02/2024 | Buy Now | 55.22% | Barclays | Andrew Mok | $101 → $104 | Maintains | Overweight | Get Alert |
04/30/2024 | Buy Now | 22.39% | Deutsche Bank | George Hill | $81 → $82 | Maintains | Hold | Get Alert |
04/29/2024 | Buy Now | 64.18% | Oppenheimer | Michael Wiederhorn | $110 → $110 | Maintains | Outperform | Get Alert |
04/15/2024 | Buy Now | 38.81% | Wells Fargo | Stephen Baxter | $89 → $93 | Maintains | Overweight | Get Alert |
04/08/2024 | Buy Now | 32.84% | Wells Fargo | Stephen Baxter | $94 → $89 | Maintains | Overweight | Get Alert |
04/04/2024 | Buy Now | 34.33% | Cantor Fitzgerald | Sarah James | → $90 | Reiterates | Overweight → Overweight | Get Alert |
03/25/2024 | Buy Now | 26.87% | Stephens & Co. | Scott Fidel | $92 → $85 | Downgrade | Overweight → Equal-Weight | Get Alert |
03/21/2024 | Buy Now | 26.87% | Stephens & Co. | Scott Fidel | $92 → $85 | Downgrade | Overweight → Equal-Weight | Get Alert |
03/20/2024 | Buy Now | 40.3% | Wells Fargo | Stephen Baxter | $90 → $94 | Maintains | Overweight | Get Alert |
03/06/2024 | Buy Now | 50.75% | Barclays | Andrew Mok | → $101 | Initiates | → Overweight | Get Alert |
01/02/2024 | Buy Now | 34.33% | Wells Fargo | Stephen Baxter | $82 → $90 | Upgrade | Equal-Weight → Overweight | Get Alert |
12/21/2023 | Buy Now | 28.36% | Truist Securities | Ryan MacDonald | $83 → $86 | Maintains | Buy | Get Alert |
12/21/2023 | Buy Now | 17.91% | UBS | Kevin Caliendo | $72 → $79 | Maintains | Neutral | Get Alert |
12/15/2023 | Buy Now | 34.33% | Cantor Fitzgerald | Sarah James | $82 → $90 | Maintains | Overweight | Get Alert |
12/13/2023 | Buy Now | 22.39% | Wells Fargo | Stephen Baxter | $74 → $82 | Maintains | Equal-Weight | Get Alert |
11/21/2023 | Buy Now | 22.39% | Cantor Fitzgerald | Sarah James | → $82 | Reiterates | Overweight → Overweight | Get Alert |
10/26/2023 | Buy Now | 10.45% | Wells Fargo | Stephen Baxter | $71 → $74 | Maintains | Equal-Weight | Get Alert |
10/09/2023 | Buy Now | 20.9% | Jefferies | David Windley | $82 → $81 | Maintains | Buy | Get Alert |
09/14/2023 | Buy Now | 22.39% | Cantor Fitzgerald | Sarah James | → $82 | Reiterates | Overweight → Overweight | Get Alert |
09/05/2023 | Buy Now | 7.46% | B of A Securities | Kevin Fischbeck | $79 → $72 | Upgrade | Underperform → Neutral | Get Alert |
08/30/2023 | Buy Now | 8.96% | Morgan Stanley | Ricky Goldwasser | $94 → $73 | Downgrade | Overweight → Equal-Weight | Get Alert |
07/31/2023 | Buy Now | 64.18% | Oppenheimer | Michael Wiederhorn | → $110 | Reiterates | Outperform → Outperform | Get Alert |
07/31/2023 | Buy Now | 26.87% | Barclays | Steve Valiquette | $86 → $85 | Maintains | Overweight | Get Alert |
07/14/2023 | Buy Now | 40.3% | Morgan Stanley | Ricky Goldwasser | $94 → $94 | Reiterates | Overweight → Overweight | Get Alert |
07/12/2023 | Buy Now | — | Wolfe Research | Justin Lake | — | Downgrade | Outperform → Peer Perform | Get Alert |
07/11/2023 | Buy Now | 13.43% | Mizuho | Ann Hynes | $80 → $76 | Maintains | Neutral | Get Alert |
07/07/2023 | Buy Now | 14.93% | JP Morgan | Calvin Sternick | $81 → $77 | Maintains | Neutral | Get Alert |
06/20/2023 | Buy Now | 23.88% | Truist Securities | Ryan MacDonald | $88 → $83 | Maintains | Buy | Get Alert |
06/20/2023 | Buy Now | 7.46% | UBS | Kevin Caliendo | → $72 | Initiates | → Neutral | Get Alert |
05/26/2023 | Buy Now | 64.18% | Oppenheimer | Michael Wiederhorn | → $110 | Reiterates | Outperform → Outperform | Get Alert |
05/26/2023 | Buy Now | 29.85% | Stephens & Co. | Scott Fidel | → $87 | Reiterates | Overweight → Overweight | Get Alert |
04/26/2023 | Buy Now | 31.34% | Truist Securities | Ryan MacDonald | $95 → $88 | Maintains | Buy | Get Alert |
04/26/2023 | Buy Now | 29.85% | Stephens & Co. | Scott Fidel | $95 → $87 | Maintains | Overweight | Get Alert |
04/26/2023 | Buy Now | 29.85% | Credit Suisse | A.J. Rice | $94 → $87 | Maintains | Outperform | Get Alert |
04/26/2023 | Buy Now | 28.36% | Barclays | Steve Valiquette | $90 → $86 | Maintains | Overweight | Get Alert |
04/21/2023 | Buy Now | 19.4% | Cantor Fitzgerald | Sarah James | → $80 | Initiates | → Overweight | Get Alert |
04/11/2023 | Buy Now | 34.33% | Barclays | Steve Valiquette | $93 → $90 | Maintains | Overweight | Get Alert |
03/21/2023 | Buy Now | 5.97% | Wells Fargo | Stephen Baxter | $79 → $71 | Maintains | Equal-Weight | Get Alert |
03/09/2023 | Buy Now | 40.3% | Morgan Stanley | Ricky Goldwasser | $103 → $94 | Maintains | Overweight | Get Alert |
03/08/2023 | Buy Now | 17.91% | Deutsche Bank | George Hill | $94 → $79 | Downgrade | Buy → Hold | Get Alert |
02/28/2023 | Buy Now | 19.4% | Mizuho | Ann Hynes | $92 → $80 | Maintains | Neutral | Get Alert |
02/23/2023 | Buy Now | 34.33% | JP Morgan | Calvin Sternick | $94 → $90 | Downgrade | Overweight → Neutral | Get Alert |
02/14/2023 | Buy Now | 44.78% | Cowen & Co. | Gary Taylor | $101 → $97 | Maintains | Outperform | Get Alert |
02/09/2023 | Buy Now | 25.37% | Goldman Sachs | Jonathan Atkin | $97 → $84 | Maintains | Neutral | Get Alert |
02/08/2023 | Buy Now | 10.45% | Goldman Sachs | Jonathan Atkin | $97 → $74 | Maintains | Neutral | Get Alert |
02/08/2023 | Buy Now | 40.3% | JP Morgan | Calvin Sternick | $98 → $94 | Maintains | Overweight | Get Alert |
02/08/2023 | Buy Now | 37.31% | Mizuho | Ann Hynes | → $92 | Maintains | Neutral | Get Alert |
02/08/2023 | Buy Now | 38.81% | Barclays | Steve Valiquette | $100 → $93 | Maintains | Overweight | Get Alert |
01/06/2023 | Buy Now | 46.27% | JP Morgan | Lisa Gill | $103 → $98 | Maintains | Overweight | Get Alert |
12/19/2022 | Buy Now | 58.21% | Credit Suisse | Jonathan Yong | $104 → $106 | Maintains | Outperform | Get Alert |
12/13/2022 | Buy Now | 26.87% | B of A Securities | Kevin Fischbeck | $100 → $85 | Downgrade | Neutral → Underperform | Get Alert |
10/03/2022 | Buy Now | 49.25% | Barclays | Steve Valiquette | $107 → $100 | Maintains | Overweight | Get Alert |
09/30/2022 | Buy Now | 34.33% | Argus Research | John Staszak | → $90 | Initiates | → Buy | Get Alert |
08/26/2022 | Buy Now | 47.76% | Wells Fargo | Stephen Baxter | → $99 | Downgrade | Overweight → Equal-Weight | Get Alert |
07/28/2022 | Buy Now | 59.7% | Barclays | Steven Valiquette | → $107 | Reinstates | → Overweight | Get Alert |
07/27/2022 | Buy Now | 37.31% | Mizuho | Ann Hynes | $84 → $92 | Maintains | Neutral | Get Alert |
07/27/2022 | Buy Now | 55.22% | Credit Suisse | A.J. Rice | $97 → $104 | Maintains | Outperform | Get Alert |
07/14/2022 | Buy Now | 52.24% | Truist Securities | David Macdonald | $100 → $102 | Maintains | Buy | Get Alert |
07/14/2022 | Buy Now | 71.64% | Jefferies | David Windley | $82 → $115 | Upgrade | Hold → Buy | Get Alert |
06/23/2022 | Buy Now | 53.73% | Morgan Stanley | Ricky Goldwasser | $112 → $103 | Maintains | Overweight | Get Alert |
06/22/2022 | Buy Now | 35.82% | Deutsche Bank | George Hill | $88 → $91 | Maintains | Buy | Get Alert |
06/21/2022 | Buy Now | 31.34% | Credit Suisse | A.J. Rice | $86 → $88 | Upgrade | Neutral → Outperform | Get Alert |
06/17/2022 | Buy Now | 49.25% | Loop Capital | Joseph France | → $100 | Initiates | → Buy | Get Alert |
05/27/2022 | Buy Now | 61.19% | Bernstein | Lance Wilkes | → $108 | Reinstates | → Outperform | Get Alert |
05/26/2022 | Buy Now | 34.33% | B of A Securities | Kevin Fischbeck | $95 → $90 | Downgrade | Buy → Neutral | Get Alert |
05/25/2022 | Buy Now | 41.79% | Wells Fargo | Stephen Baxter | $96 → $95 | Maintains | Overweight | Get Alert |
04/27/2022 | Buy Now | 67.16% | Morgan Stanley | Ricky Goldwasser | $109 → $112 | Maintains | Overweight | Get Alert |
02/09/2022 | Buy Now | 31.34% | Deutsche Bank | George Hill | $84 → $88 | Maintains | Buy | Get Alert |
02/09/2022 | Buy Now | 25.37% | Mizuho | Ann Hynes | $78 → $84 | Maintains | Neutral | Get Alert |
01/07/2022 | Buy Now | 41.79% | Barclays | Steve Valiquette | → $95 | Reinstates | → Overweight | Get Alert |
12/17/2021 | Buy Now | 62.69% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
12/14/2021 | Buy Now | 23.88% | Goldman Sachs | Nathan Rice | — | Initiates | → Neutral | Get Alert |
12/13/2021 | Buy Now | 49.25% | BMO Capital | Matt Borsch | — | Maintains | Outperform | Get Alert |
12/13/2021 | Buy Now | 41.79% | Oppenheimer | Michael Wiederhorn | — | Maintains | Outperform | Get Alert |
12/13/2021 | Buy Now | 34.33% | Wells Fargo | Stephen Baxter | — | Maintains | Overweight | Get Alert |
12/13/2021 | Buy Now | 28.36% | Credit Suisse | — | — | Maintains | Neutral | Get Alert |
10/27/2021 | Buy Now | 28.36% | Morgan Stanley | Ricky Goldwasser | — | Maintains | Overweight | Get Alert |
10/27/2021 | Buy Now | 11.94% | Credit Suisse | Jonathan Yong | — | Maintains | Neutral | Get Alert |
09/14/2021 | Buy Now | 17.91% | Morgan Stanley | Ricky Goldwasser | — | Maintains | Overweight | Get Alert |
09/14/2021 | Buy Now | 4.48% | Credit Suisse | Jonathan Yon | — | Maintains | Neutral | Get Alert |
08/31/2021 | Buy Now | 31.34% | Morgan Stanley | Craig Hettenbach | — | Maintains | Overweight | Get Alert |
08/03/2021 | Buy Now | 31.34% | Wells Fargo | Stephen Baxter | — | Maintains | Overweight | Get Alert |
The latest price target for Centene (NYSE:CNC) was reported by Wells Fargo on July 22, 2024. The analyst firm set a price target for $81.00 expecting CNC to rise to within 12 months (a possible 20.90% upside). 31 analyst firms have reported ratings in the last year.
The latest analyst rating for Centene (NYSE:CNC) was provided by Wells Fargo, and Centene maintained their overweight rating.
The last upgrade for Centene Corp happened on January 2, 2024 when Wells Fargo raised their price target to $90. Wells Fargo previously had an equal-weight for Centene Corp.
The last downgrade for Centene Corp happened on March 25, 2024 when Stephens & Co. changed their price target from $92 to $85 for Centene Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Centene, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Centene was filed on July 22, 2024 so you should expect the next rating to be made available sometime around July 22, 2025.
While ratings are subjective and will change, the latest Centene (CNC) rating was a maintained with a price target of $93.00 to $81.00. The current price Centene (CNC) is trading at is $67.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.